BCYP

Big Cypress Acquisition Corp. (BCYP) | Rumor.io

Big Cypress Acquisition

BCYP

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about BCYP?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Nov 2

Big Cypress Acquisition Corp. (BCYP) is a biopharmaceutical company making antibodies.
The company's low float status may lead to volatility, but the direction of the stock is determined by market participants.
BCYP has filed a SEC Form SC 13D, indicating significant shareholder activity.

Generated by AI

Sentiment

Of the messages about BCYP that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	—
Bearish	—	—	—	—

Oct 22

$BCYP is a low-float SPAC that can be volatile, but has already shown a 17% increase this week and warrants up 36% from entry.
The company has a government-funded program through Operation Warp Speed, which could lead to a major squeeze and uptrend if the stock breaks over the VWAP.
A merger is scheduled for next week, which could lead to a big move in the stock, especially considering the current trend of SPACs being hot.

Generated by AI

Topics

Of the messages about BCYP that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Jun 22

Big Cypress Acquisition Corp. ($BCYP) is merging with SAB Biotherapeutics, a clinical-stage biopharmaceutical company, to take it public on the Nasdaq.
The merger will advance SAB's unique human antibody platform, which has demonstrated utility in immunotherapy and rapid response to emerging diseases, according to the company's investors presentation.
The deal has an estimated enterprise value of $325 million and no private investment in public equity (PIPE), with $116 million in trust at $10.10 per share.

Generated by AI

Community

Of the messages about BCYP, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	—
Newcomers	—	—	—	—

Also Discussed

Investors talking about BCYP also mention

#	Name	Attention
1	OCAX - OCA Acquisition Corp.	——
2	TMKR - Tastemaker Acquisition Corp.	——
3	SAB Biotherapeutics Inc.SABS	0%new
4	SDAC - Sustainable Development Acquisition I Corp.	——
5	PTIC - PropTech Investment Corporation II	——
6	FSII - FS Development Corp. II	——
7	VCKA - Vickers Vantage Corp. I	——
8	INKA - KludeIn I Acquisition Corp.	——
9	KINZ - KINS Technology Group Inc.	——
10	Sab Biotherapeutics Inc.SABSW	0%new